Anantam IASPost · 17 April 2026

Genome Sequencing — Human Genome, IndiGen, Genome India Project (UPSC Science & Tech)

Study Notes · General Studies · GS III · Science & Tech

Genome sequencing — DNA, Human Genome Project, Genome India Project, IndiGen, applications in medicine and agriculture — UPSC GS III notes.

In April 2024, the Department of Biotechnology announced that the Genome India Project (GIP) had completed whole-genome sequencing of 10,000 Indians from across 99 population groups. For the first time, a high-resolution genetic map of India's extraordinarily diverse population exists — a reference that could transform how Indian patients are diagnosed, how Indian crops are bred, and how Indian ancestry is understood.

Genome sequencing is a high-frequency UPSC GS III theme because it sits at the meeting point of biotechnology, health, agriculture, data protection and ethics.

What is a Genome

Variations in the Genome — diagram from the Anantam IAS Mains QIP handout
Variations in the Genome

What is Genome Sequencing

Genome sequencing determines the exact order of all 3 billion base pairs in an organism's DNA. It is like reading the entire recipe book, letter by letter, to find spelling mistakes.

Types

Non-coding regions regulate gene expression; WGS is needed to catch mutations outside exons.

Applications

Medicine

Agriculture

Forensics

Evolution and Ancestry

Environmental

Key Programmes

Human Genome Project (HGP, 1990-2003)

IndiGen Programme (2019)

Genome India Project (GIP, 2020-2024)

Genome Mapping in the Indian Ocean (2021)

INSACOG (2020-present)

India-Specific Genetic Insights

Cost and Technology Trend

Concerns

Institutional Framework

Latest Developments (2024-26)

UPSC Relevance

Prelims angles

Mains angles

Essay angles

Practice question — "Genome sequencing is transformative but ethically fraught. Discuss with reference to Indian initiatives."

A decade ago, sequencing an Indian genome was a billion-dollar academic question; today it is a research tool, a public-health asset and a commercial product. The challenge now is building the ethical, legal and clinical infrastructure to use it well.